← Leaderboards
Megan McNerney
University Of Chicago
$6,106,581
Attributed
$6,106,581
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $933.3K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,106,581 · 5
By mechanism
R01$5,225,126 · 3
K08$845,640 · 1
F32$35,815 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Michelle M Le Beau$39,023,275
- Lucy Ann Godley$5,215,217
- Elizabeth M McNally$39,500,544
- Sriram Sundaravel$468,844
- David J. Grdina$4,132,498
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationMolecularPathogenesisGenesIn VivoTranscriptional RegulationChromosome 7q LossTranscription FactorKnock-DownSelf-RenewalMyelogenousPathway InteractionsPharmaceutical PreparationsMyeloproliferative DiseaseMouse ModelNew Therapeutic TargetGeneticChromosome AbnormalityBlood CellsFutureHematopoieticRecurrenceHomeodomainNovel Therapeutics
Grant awards (19)
Establishing CUX1 as a determinant of hematopoietic stem cell fate$474,898
R01 · FY2025 · HL · contact PI
Establishing CUX1 as a determinant of hematopoietic stem cell fate$465,400
R01 · FY2024 · HL · contact PI
Establishing CUX1 as a determinant of hematopoietic stem cell fate$474,898
R01 · FY2023 · HL · contact PI
Regulation of hematopoiesis by CUX1$399,048
R01 · FY2022 · HL · contact PI
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia$365,129
R01 · FY2022 · CA · contact PI
Regulation of hematopoiesis by CUX1$399,048
R01 · FY2021 · HL · contact PI
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia$365,129
R01 · FY2021 · CA · contact PI
Regulation of hematopoiesis by CUX1$399,048
R01 · FY2020 · HL · contact PI
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia$365,129
R01 · FY2020 · CA · contact PI
Regulation of hematopoiesis by CUX1$399,048
R01 · FY2019 · HL · contact PI
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia$354,174
R01 · FY2019 · CA · contact PI
Regulation of hematopoiesis by CUX1$399,048
R01 · FY2018 · HL · contact PI
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia$365,129
R01 · FY2018 · CA · contact PI
Determining the role of CUX1 in myeloid neoplasia$169,128
K08 · FY2018 · CA · contact PI
Determining the role of CUX1 in myeloid neoplasia$169,128
K08 · FY2017 · CA · contact PI
Determining the role of CUX1 in myeloid neoplasia$169,128
K08 · FY2016 · CA · contact PI
Determining the role of CUX1 in myeloid neoplasia$169,128
K08 · FY2015 · CA · contact PI
Determining the role of CUX1 in myeloid neoplasia$169,128
K08 · FY2014 · CA · contact PI
Next-Generation Sequencing of Therapy-Related Acute Myeloid Leukemia$35,815
F32 · FY2010 · CA · contact PI